Answers are grounded in this paper and cite their sources.
Cariogenic biofilms primarily associated with Streptococcus mutans and Lactobacillus acidophilus contribute to one of the most prevalent chronic oral diseases worldwide. Although current Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) systems are effective in remineralization, they lack direct biofilm-disrupting capabilities, highlighting the need for multifunctional materials. A biogenic Ag-HAp-MSN nanocomposite, previously synthesized using Cissus quadrangularis extract and confirmed to possess favourable physicochemical properties and cytocompatibility, was evaluated for its antibacterial and anti-biofilm efficacy. Antibacterial activity was assessed using agar well diffusion, Minimum Inhibitory Concentration (MIC), and Minimum Bactericidal Concentration (MBC) assays, while anti-biofilm activity was analysed via crystal violet inhibition, acridine orange/ethidium bromide (AO/EB) live-dead fluorescence, and Confocal Laser Scanning Microscopy (CLSM). GC Tooth Mousse served as a contextual clinical reference. At 1000 µg/mL, the nanocomposite produced ZOI values of 25 mm ( S. mutans ) and 29 mm ( L. acidophilus ), outperforming all individual components. The MIC values were 250 µg/mL ( S. mutans ) and 125 µg/mL ( L. acidophilus ), representing a 2–4-fold improvement, with MBC/MIC ratios of 2, confirming bactericidal action. Crystal violet biofilm inhibition reached 82.53% and 87.53%, while AO/EB dead-cell fractions were 83.63% and 89.33%, respectively ( p < 0.001 vs. all controls). Under agar diffusion conditions, the nanocomposite showed inhibition zones comparable to GC Tooth Mousse against L. acidophilus at 800 µg/mL. These findings support further investigation of biogenic Ag-HAp-MSN nanocomposite for anti-cariogenic applications.
No takes yet. Share an insight, caveat, or question.
Krishnakumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: